Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | 0 | déclaré | 18 nov. 2024 | tx 22+543 166−116 535 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 18 nov. 2024 | SALE | Syros Pharmaceuticals, Inc. | 36 133 | 0.22 USD | |
| 31 oct. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6 104 | 2.09 USD | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | — | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | 0.00 USD | deriv |
| 01 avr. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 4 218 | 5.12 USD | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11 666 | — | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11 666 | 0.00 USD | deriv |
| 01 nov. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 5 676 | 2.22 USD | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | — | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17 000 | 0.00 USD | deriv |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 03 avr. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 623 | 2.58 USD | |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 16 févr. 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35 000 | 0.00 USD | deriv |
| 06 oct. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 34 000 | 0.00 USD | deriv |
| 06 oct. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 44 500 | 0.00 USD | deriv |
| 01 avr. 2022 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 14 115 | 1.12 USD | |
| 15 févr. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 100 000 | 0.00 USD | deriv |
| 15 févr. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 80 000 | 0.00 USD | deriv |
| 15 févr. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 200 000 | 0.00 USD | deriv |